DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) – Larimar Therapeutics, Inc. Transaction History
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio value:
$54.21M
portfolio value
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) quarter portfolio value change:
+63.27%
quarter
Larimar Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +190.58% | 11.11M shares | 42.78M | $3.2 | 16.94M |
| Q2 2022 | share | 0.00% | 0 shares | -12.18M | $1.96 | 5.83M | |
| Q1 2022 | share | 0.00% | 0 shares | -39.29M | $4.05 | 5.83M | |
| Q4 2021 | share | 0.00% | 0 shares | -4.31M | $10.89 | 5.83M | |
| Q3 2021 | share | 0.00% | 0 shares | 9.97M | $11.53 | 5.83M | |
| Q2 2021 | share | Increase | +13.33% | 685.71K shares | -17.90M | $9.82 | 5.83M |
| Q1 2021 | share | 0.00% | 0 shares | -34.98M | $14.61 | 5.14M | |
| Q4 2020 | share | 0.00% | 0 shares | 32.10M | $21.41 | 5.14M | |
| Q3 2020 | share | 0.00% | 0 shares | 11.93M | $15.17 | 5.14M | |
| Q2 2020 | share | Increase | 0.00% | 5.14M shares | 66.10M | $12.85 | 5.14M |